- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01960699
Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation
Background: Cardiac arrest is a life-threatening event. Intensivists are challenged with an increasing number of patients with uncertain neurological outcome following cardiopulmonary resuscitation (CPR). The prognostic value of current biomarkers for neurophysiologic long-term outcome is limited.
Hypothesis: We hypothesize that specific brain-derived tissue leakage proteins can be identified to reveal novel, more reliable prognostic biomarkers for good neurological outcome.
Methods: This translational study (n=100) is a combination of a prospective basic science study intended to reduce the number of potential plasma biomarker candidates by proteomic shotgun analyses in brain tissue autopsy samples and plasma samples from resuscitated patients (n=10) and a prospective clinical validation study in a large study population (n=90) by high-throughput analyses. Selection of proteomic markers and signature estimation will be performed to discriminate patients with good and poor outcome.
Clinical perspective: A structured proteomic analysis approach might identify the best marker out of all proteins liberated during cellular damage.
Study Overview
Status
Conditions
Detailed Description
Background: Cardiac arrest is a life-threatening event. Intensivists are challenged with an increasing number of patients with uncertain neurological outcome following cardiopulmonary resuscitation (CPR). The prognostic value of current biomarkers for neurophysiologic long-term outcome is limited. Therefore, identification of novel plasma markers with higher predictive value for neurophysiological recovery is critical for patient management after CPR.
Hypothesis: We hypothesize that specific brain-derived tissue leakage proteins can be identified to reveal novel, more reliable prognostic biomarkers for good neurological outcome.
Methods: This translational study (n=100) is a combination of a prospective basic science study intended to reduce the number of potential plasma biomarker candidates by proteomic shotgun analyses in brain tissue autopsy samples and plasma samples from resuscitated patients (n=10) and a prospective clinical validation study in a large study population (n=90) by high-throughput analyses. Samples will be analyzed by proteomic shotgun analyses using the Q-Exactive quadrupole-orbitrap mass spectrometer (MS). MS/MS data will be interpreted by the MaxQuant and Perseus Software. In order to identify brain-derived proteins within plasma, the plasma proteome of 10 resuscitated patients will be compared to the proteomic profile of brain tissue. This will reduce the number of potential plasma biomarker candidates associated with neurologic outcome. The prospective validation in plasma samples will be performed by a targeted proteomics approach using selected reaction monitoring (SRM) on a triple quadrupole ion MS. Neurological outcome will be assessed by the five-point scale (death, persistent vegetative state, severe disability, moderate disability, and good recovery) according to the cerebral performance categories (CPC). A CPC sore of <3 is considered a good neurological outcome. Selection of proteomic markers and signature estimation will be performed by L1 regularized logistic regression, where the tuning parameter will be optimized by cross-validated model performance. The signature's ability to discriminate patients with good and poor outcome will be described by ROC analysis.
Clinical perspective: An accurate predictor of neurological outcome following CPR is of utmost clinical importance. However, previous studies focused on a very limited array of biomarkers. Therefore, a structured proteomic analysis approach might identify the best marker out of all proteins liberated during cellular damage.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- Medical University of Vienna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Nontraumatic, normothermic cardiac arrest due to cardiac disorders, respiratory failures, or hemodynamic or metabolic factors.
- A Glasgow Coma Scale of 3, none of the patients will be conscious at the time of hospital admission.
- No previous cardiac arrest, as well as known or coexisting neurological disorders or neoplasms of the central nervous system.
- No history of psychiatric illness, no alcohol or drug dependency, and no psychotropic medication.
- Initiation of mild therapeutic hypothermia
Exclusion Criteria:
- hydrocephalus and shunt artifact
- severe movement artifacts
- intracerebral hemorrhage
- old large ischemic lesion
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
CPC < 3
Good neurological outcome
|
CPC >/= 3
Unvavourable neurologic outcome
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cerebral performance categories (CPC)of <3
Time Frame: participants will be followed for the duration of intensive-care unit stay, an expected average of 2 weeks.
|
participants will be followed for the duration of intensive-care unit stay, an expected average of 2 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cerebral performance categories (CPC)of <3
Time Frame: 6 Months
|
6 Months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Brain glucose metabolism
Time Frame: Day 1 after end of cooling period
|
Day 1 after end of cooling period
|
Clinical outcome (rehospitalization and death)
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christopher Adlbrecht, MD, Medical University of Vienna
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK_Nr_1740/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Arrest With Successful Resuscitation
-
Stefano Malinverni, MDAndre Vesale AssociationRecruitingCardiac Arrest With Successful ResuscitationBelgium
-
University of ThessalyTerminatedCardiopulmonary Arrest With Successful Resuscitation | Cardiac ArrestGreece
-
Mario Negri Institute for Pharmacological ResearchRecruitingCardiac Arrest With Successful Resuscitation | Cardiac Arrest, Out-Of-HospitalItaly
-
University of PennsylvaniaWithdrawnCardiopulmonary Arrest With Successful Resuscitation | Cardiac Arrest | Echocardiography, Transesophageal | In-hospital Cardiac Arrest | ACLS | Image Guided ACLS
-
Dr. Serge ThalActive, not recruitingCardiopulmonary Arrest With Successful Resuscitation | Cardiac Arrest | Cerebral OxygenationGermany
-
Odense University HospitalUniversity of Southern Denmark; Odense Patient Data Explorative Network; REHPA... and other collaboratorsCompletedCardiac Arrest With Successful ResuscitationDenmark
-
Sahlgrenska University Hospital, SwedenGöteborg UniversityRecruitingCardiopulmonary Arrest With Successful Resuscitation | Cardiac Arrest | ResuscitationSweden
-
Medical University of ViennaCompletedCardiopulmonary Arrest With Successful Resuscitation | Cardiac Arrest | Cardiopulmonary Arrest | Cardiac Arrest, Out-Of-HospitalAustria
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); Emergency Medicine FoundationCompletedCardiac Arrest With Successful ResuscitationUnited States
-
Adam FrischBrainCoolCompletedCardiac Arrest With Successful ResuscitationUnited States